Flexbumin is a Intravenous Injection, Solution in the Plasma Derivative category. It is labeled and distributed by Baxalta Us Inc.. The primary component is Albumin Human.
Product ID | 0944-0495_22af2f71-74f4-4a01-99fb-bc9878174ff8 |
NDC | 0944-0495 |
Product Type | Plasma Derivative |
Proprietary Name | Flexbumin |
Generic Name | Albumin Human |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2014-07-31 |
Marketing Category | BLA / BLA |
Application Number | BLA101452 |
Labeler Name | Baxalta US Inc. |
Substance Name | ALBUMIN HUMAN |
Active Ingredient Strength | 0 g/mL |
Pharm Classes | Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2014-07-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA101452 |
Product Type | PLASMA DERIVATIVE |
Billing Unit | ML |
Marketing Start Date | 2014-07-31 |
Ingredient | Strength |
---|---|
ALBUMIN HUMAN | .05 g/mL |
NDC | Brand Name | Generic Name |
---|---|---|
0944-0493 | FLEXBUMIN | Albumin Human |
0944-0495 | Flexbumin | Albumin Human |
67467-623 | Albumin (Human) | Albumin Human |
67467-633 | Albumin (Human) | Albumin Human |
67467-643 | Albumin (Human) | Albumin Human |
68982-623 | Albumin (Human) | Albumin Human |
68982-633 | Albumin (Human) | Albumin Human |
68982-643 | Albumin (Human) | Albumin Human |
64208-2510 | ALBUMINEX | Albumin Human |
64208-2512 | ALBUMINEX | Albumin Human |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
FLEXBUMIN 78122148 3083369 Live/Registered |
BAXALTA INCORPORATED 2002-04-16 |